159 related articles for article (PubMed ID: 19004675)
21. Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon alpha-2a and ribavirin.
Yu JW; Wang GQ; Sun LJ; Li XG; Li SC
J Gastroenterol Hepatol; 2007 Jun; 22(6):832-6. PubMed ID: 17565637
[TBL] [Abstract][Full Text] [Related]
22. Patient's age modifies the impact of the proposed predictors of sustained virological response in chronic hepatitis C patients treated with PEG-interferon plus ribavirin.
Elefsiniotis IS; Pavlidis C; Ketikoglou I; Koutsounas S; Scarmeas N; Pantazis KD; Moulakakis A; Tsianos EV
Eur J Intern Med; 2008 Jun; 19(4):266-70. PubMed ID: 18471675
[TBL] [Abstract][Full Text] [Related]
23. Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and sustained virological responses.
Inoue Y; Hiramatsu N; Oze T; Yakushijin T; Mochizuki K; Hagiwara H; Oshita M; Mita E; Fukui H; Inada M; Tamura S; Yoshihara H; Hayashi E; Inoue A; Imai Y; Kato M; Miyagi T; Hohsui A; Ishida H; Kiso S; Kanto T; Kasahara A; Takehara T; Hayashi N
J Viral Hepat; 2010 May; 17(5):336-44. PubMed ID: 19678893
[TBL] [Abstract][Full Text] [Related]
24. Prognostic effect of human leukocyte antigen class I and II alleles on chronic hepatitis C patients treated by pegylated interferon-alfa plus ribavirin in Taiwan.
Tseng KC; Chang CK; Chou AL; Hsieh YH; Tseng CA; Lai NS
Hepatogastroenterology; 2010; 57(99-100):456-61. PubMed ID: 20698208
[TBL] [Abstract][Full Text] [Related]
25. Reversal of hypolipidemia in chronic hepatitis C patients after successful antiviral therapy.
Kuo YH; Chuang TW; Hung CH; Chen CH; Wang JH; Hu TH; Lu SN; Lee CM
J Formos Med Assoc; 2011 Jun; 110(6):363-71. PubMed ID: 21741004
[TBL] [Abstract][Full Text] [Related]
26. Single-nucleotide polymorphism of Toll-like receptor 4 and interleukin-10 in response to interferon-based therapy in Egyptian chronic hepatitis C patients.
Sadik NA; Shaker OG; Ghanem HZ; Hassan HA; Abdel-Hamid AH
Arch Virol; 2015 Sep; 160(9):2181-95. PubMed ID: 26095186
[TBL] [Abstract][Full Text] [Related]
27. CD209 promoter polymorphisms associate with HCV infection and pegylated-interferon plus ribavirin treatment response.
Zupin L; Polesello V; Alberi G; Moratelli G; Crocè SL; Masutti F; Pozzato G; Crovella S; Segat L
Mol Immunol; 2016 Aug; 76():49-54. PubMed ID: 27348632
[TBL] [Abstract][Full Text] [Related]
28. Influence of IL10 Gene polymorphisms on the sustained virologic response of patients with chronic hepatitis C to PEG-interferon/ribavirin therapy.
Guo P; Li G; Sun X; Wu D
Infect Genet Evol; 2016 Nov; 45():48-55. PubMed ID: 27543394
[TBL] [Abstract][Full Text] [Related]
29. Tumour necrosis factor -308 and -238 promoter polymorphisms are predictors of a null virological response in the treatment of Brazilian hepatitis C patients.
Grandi T; Silva CM; Amaral KM; Picon PD; Costi C; Fré NN; Fiegenbaum M; Gregianini TS; Niel C; Rossetti ML
Mem Inst Oswaldo Cruz; 2014 Jun; 109(3):345-51. PubMed ID: 24789557
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy.
Lange CM; Bojunga J; Ramos-Lopez E; von Wagner M; Hassler A; Vermehren J; Herrmann E; Badenhoop K; Zeuzem S; Sarrazin C
J Hepatol; 2011 May; 54(5):887-93. PubMed ID: 21145801
[TBL] [Abstract][Full Text] [Related]
31. [Association between raised IL-8 serum levels and resistance to combined peg-interferon plus ribavirin therapy in HCV+ active chronic hepatitis].
Cacopardo B; Nigro L; Nunnari G; La Medica G; Cappellani A; Palermo F; Cappello E; Russo R
Infez Med; 2008 Jun; 16(2):80-5. PubMed ID: 18622147
[TBL] [Abstract][Full Text] [Related]
32. Application of interferon response-related gene array to the antiviral treatment outcome in chronic hepatitis C.
Xing TJ; Xv HT; Zhao W; Shen L; Li H; Cai RT
Hepatogastroenterology; 2010; 57(102-103):1257-63. PubMed ID: 21410068
[TBL] [Abstract][Full Text] [Related]
33. CD24 Ala57Val polymorphism is associated with spontaneous viral clearance in the HCV-infected Chinese population.
Sun H; Pan Y; Wu R; Lv J; Chi X; Wang X; Tu Z; Zhong J; Sun B; Liu Y; Jiang J; Niu J
Liver Int; 2015 Mar; 35(3):786-94. PubMed ID: 25872416
[TBL] [Abstract][Full Text] [Related]
34. Impact of the IL-18 gene polymorphism in response to antiviral therapy in chronic HCV genotype 4 patients.
Mandour M; Nemr N; Kishk R; Ahmed E
Rev Soc Bras Med Trop; 2014; 47(2):137-42. PubMed ID: 24861285
[TBL] [Abstract][Full Text] [Related]
35. Association of SCARB1 Gene Polymorphisms with Virological Response in Chronic Hepatitis C Patients Receiving Pegylated Interferon plus Ribavirin Therapy.
Hsu CS; Hsu SJ; Liu WL; Chen DS; Kao JH
Sci Rep; 2016 Aug; 6():32303. PubMed ID: 27561198
[TBL] [Abstract][Full Text] [Related]
36. Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C.
Su X; Yee LJ; Im K; Rhodes SL; Tang Y; Tong X; Howell C; Ramcharran D; Rosen HR; Taylor MW; Liang TJ; Yang H;
J Hepatol; 2008 Aug; 49(2):184-91. PubMed ID: 18571276
[TBL] [Abstract][Full Text] [Related]
37. [Genetic polymorphisms as new predictive factors for successful treatment of chronic hepatitis C].
Válková I; Kristian P; Schréter I; Habalová V
Klin Mikrobiol Infekc Lek; 2011 Dec; 17(6):190-3. PubMed ID: 22247028
[TBL] [Abstract][Full Text] [Related]
38. Functional Polymorphism in the Interleukin 6 (IL6) Gene with Respect to Depression Induced in the Course of Interferon-α and Ribavirin Treatment in Chronic Hepatitis Patients.
Frydecka D; Pawłowski T; Pawlak D; Małyszczak K
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):169-175. PubMed ID: 28083615
[TBL] [Abstract][Full Text] [Related]
39. Response to combination therapy with interferon alfa-2a and ribavirin in chronic hepatitis C according to a TNF-alpha promoter polymorphism.
Schiemann U; Glas J; Török P; Simperl C; Martin K; König A; Schmidt F; Schaefer M; Folwaczny C
Digestion; 2003; 68(1):1-4. PubMed ID: 12949432
[TBL] [Abstract][Full Text] [Related]
40. Involvement of the Interleukin-23/Interleukin-17 Axis in Chronic Hepatitis C Virus Infection and Its Treatment Responses.
Meng P; Zhao S; Niu X; Fu N; Su S; Wang R; Zhang Y; Qiao L; Nan Y
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
